METABolic Deterioration in HTX Determines Outcomes — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

METABolic Deterioration in HTX Determines Outcomes — Stella

Home/Heart Transplantation/

View on ClinicalTrials.gov

Recruiting

Back to Heart Transplantation trials

Trial locations(1 site)

Germany

University-Hospital Düsseldorf Division of Cardiology, Pneumology and Angiology, Düsseldorf, North Rhine-Westphalia

Key details

Sponsor

Heinrich-Heine University, Duesseldorf

Enrollment target

~270 participants

Started

July 2025

Primary completion

April 2030

Age range

18 Years and older

Last updated January 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.